Skip to content

Efficacy of Using a Closing Pack to Reduce Postpartum Sepsis

A Randomised Trial to Evaluate the Efficacy and Feasibility of a Closing Pack to Reduce the Rate of Surgical Site Infection Following Caesarean Section

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05632705
Enrollment
1000
Registered
2022-11-30
Start date
2021-03-08
Completion date
2022-04-30
Last updated
2022-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of Postpartum Sepsis

Brief summary

Randomised trial comparing the efficacy and feasibility of using a sterile closing pack to reduce postpartum sepsis

Detailed description

Pregnant patients meeting the inclusion criteria undergoing elective or emergency caesarean section will be eligible for recruitment. Patients will be randomised into two arms. In the control arm sheath and skin closure will be performed with the instruments used to perform the caesarean section, as per the current standard of care. In the intervention arm, after suturing the uterine incision and obtaining hemostasis and before commencing closure of the sheath and skin, the surgical team (obstetrician, assistant and scrub sister) will don clean sterile gloves, open clean sterile linen to drape on top of the existing linen and open a pack of clean sterile instruments to close the sheath and skin.

Interventions

OTHERClosing pack

A closing pack, new sterile gloves and new sterile drapes will be used when commencing closure of the sheath and skin

Sponsors

University of Pretoria
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

The outcomes assessor will not have information with regards to the intervention arms

Intervention model description

Randomised trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* women 18 years and older willing and able to provide consent

Exclusion criteria

* women who are not able or willing to provide consent patients with existing maternal infection

Design outcomes

Primary

MeasureTime frameDescription
Efficacy to reduce surgical site infections within seven daysSeven days post-operativelyIncidence of surgical site infections in both arms

Secondary

MeasureTime frameDescription
Efficacy to reduce postpartum endometritis within seven daysSeven days post-operativelyIncidence of postpartum endometritis in both arms
Feasibility of using a closure packAt the time of caesarean sectionAssess the availability as well as use of the sterile closing pack

Countries

South Africa

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026